Full-Time
Site Technology Specialist
PSI CRO
1,001-5,000 employees
Global CRO delivering on-time patient enrollment
No salary listed
No H1B Sponsorship
Remote in USA
Remote
 Biology & Biotech (1) |
|---|
Get referred to PSI CRO
See people who can refer or advise you
- MRI experience required
- MRI Certification preferred
- Previous experience as a nuclear medicine technologist is a plus
- Clinical trial experience is a plus
- Associate degree required, bachelor's degree preferred
- PSI does not hire individuals who require work visa for employment or continued employment now or anytime in the future
- Provides clinical sites with technical support and expertise related to technology.
- Assists in the design and implementation of study related forms, guidelines and manuals related to technologies.
- Coordinates data collection related to technologies, including but not limited to nuclear medicine, radiology, etc.
- Provides technical and initiation support to sites.
- Identifies, tracks, and reports specific technical timepoints in the study related to study procedures including imaging, scans, and other technologies.
- Determines technical resources needed for project implementation, and communicates needs to department managers.
- Organizes technical training for project teams.
- Provides support to the project teams to ensure proper documentation of study-specific assessments related to study technologies.
- Supports site initiation preparation and performs technical visits to assist the site team with technical aspects of the study.
- Assists and advises the site monitor in the area of study technologies.
- Provides relevant technology-related information to Business Development for proposals.
PSI CRO is a global contract research organization that handles clinical trials for multiple therapeutic areas, with a focus on enrolling patients on schedule and delivering studies on time. Its services span feasibility assessments, trial planning, site selection, patient recruitment, and multi-continent trial execution across 50+ countries, backed by medical doctor resources dedicated to accurate timeline predictions. Unlike many CROs, PSI emphasizes predictable enrollment and on-time project delivery, aiming for high client satisfaction and repeat business through a pragmatic, no-nonsense approach. The company’s goal is to be regarded as the best CRO in the world by both clients and employees, achieved through reliable timelines, strong execution, and low staff turnover.
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Switzerland
Founded
1995
Get referred to PSI CRO
See people who can refer or advise you
Simplify's Take
What believers are saying
- Beijing improves proximity to Chinese regulators and investigator sites.
- Toronto expansion supports North American phase II and III growth.
- Japan leadership strengthens local execution across Asia-Pacific.
What critics are saying
- China operations face tighter oversight, data-access limits, and policy shifts.
- AI site selection depends on fragmented data quality and sponsor trust.
- New offices raise fixed costs before revenue catches up.
What makes PSI CRO unique
- Swiss-based CRO with a growing China presence in Shanghai and Beijing.
- SYNETIC cuts trial site identification from weeks to minutes.
- Global full-service execution spans 50+ countries across planning through delivery.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Paid Vacation
Flexible Work Hours
Hybrid Work Options
Remote Work Options
Wellness Program
Mental Health Support
Conference Attendance Budget
Professional Development Budget
Company News
PSI CRO, a global clinical research organisation, has reduced clinical trial site identification from up to six weeks to minutes using SYNETIC, an AI knowledge engine powered by the Arango Contextual Data Platform. The system helps identify higher-performing trial sites and minimise costly non-enrolling institutions, which account for 30-40% of trial sites. Clinical trials can cost over $160 per minute operationally, and activating a trial site costs $30,000 or more. With 15% of sites never enrolling a single patient, failed recruitment can cost millions per study. SYNETIC unifies fragmented clinical research data into a single contextual layer, preserving relationships across investigators, institutions, protocols and historical outcomes. The platform provides explainable AI recommendations, including rationale, supporting evidence and confidence levels, enabling data-driven site selection in minutes rather than weeks.
PSI CRO strengthens Canadian presence with new Toronto office and leadership role. PSI CRO has broadened its footprint in Canada by opening a new office in the Toronto area and naming an experienced industry leader to guide its operations there. The office, located in Mississauga, Ontario, builds on the company's established Canadian presence and commitment to clinical research excellence. PSI CRO has been active in Canada for over a decade, supporting complex clinical trials with a focus on dependable delivery and strong relationships with research sites. As part of this expansion, David Allen, MBA, has been appointed as Country Manager for Canada. Allen brings more than 30 years of experience in clinical research from both sponsor and CRO environments. In his new role, he will lead efforts to enhance the company's operational capabilities in the local market and ensure alignment with PSI's global standards for on-time trial execution. PSI's continued growth in North America reflects broader trends of increasing trial activity in the region, particularly for pivotal phase II and phase III studies where precision and efficiency are critical. The expanded Toronto operations aim to further support sponsors with rigorous trial planning and execution.
TOKYO, 14 March 2025 - PSI CRO AG, a global Swiss-based clinical research organization (CRO), is pleased to announce the appointment of Sayaka Kaji as Country Manager for Japan.
Psi CRO Ag launched a CRA Academy to provide to help its team members develop therapeutic expertise as well as soft skills to manage key relationships with sites.
This is also the fourth year in a row in which PSI CRO received CRO Leadership Awards in all five categories, also including Expertise and Capabilities, across two respondent groups.